7UX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Spago Nanomedical AB (publ)

Watchlist Manager

Watchlist

Price: 0.0092 EUR Market Closed

Market Cap: €3.2m

	Spago Nanomedical AB (publ) F:7UX	SE
I	Imperial Ginseng Products Ltd XTSX:IGP	CA
E	Exacompta Clairefontaine SA F:8KG	FR
N	Nevada Exploration Inc OTC:NVDEF	CA
L	LightPath Technologies Inc F:LPZB	US
	Shinwa Co Ltd TSE:3447	JP

Profitability Summary

Spago Nanomedical AB (publ)'s profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

81%

Negative Operating Margin

-21 806%

Negative 3Y Average Operating Margin

-4 813%

Declining Operating Margin

-5 776% > -21 806%

Negative Net Margin

-21 419%

Negative 3Y Average Net Margin

-4 729%

Declining Net Margin

-5 679% > -21 419%

Negative Free Cash Flow Margin

-20 766%

Negative 3Y Average Free Cash Flow Margin

-4 743%

Declining Free Cash Flow Margin

-6 116% > -20 766%

Negative ROE

-104%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-536%

Declining ROIC

-25% > -1 431%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.